Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IRD
IRD logo

IRD News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IRD News

Opus Genetics Updates on Gene Therapy Developments

3d agoNASDAQ.COM

Wall Street's Latest Ratings and Price Target Adjustments

Jun 04 2026CNBC

Opus Genetics Reports Q1 Losses and Revenue Decline

May 12 2026seekingalpha

Opus Genetics Reports Vision Restoration Data in Pediatric Patients

May 07 2026Newsfilter

Opus Genetics Receives FDA RDEP Designation for LCA5 Gene Therapy

May 05 2026NASDAQ.COM

Opus Genetics' OPGx-LCA5 Accepted into FDA's Rare Disease Program

May 04 2026Newsfilter

Opus Genetics to Present Three Studies at ASCRS Annual Meeting

Apr 10 2026Newsfilter

Opus Genetics Presents New Research at ASCRS Meeting

Apr 10 2026Yahoo Finance

IRD Events

06/05 16:40
Company Not Selling 2.68M Shares of Common Stock
This filing relates to the offer and sale from time to time by the selling stockholder of up to 2.68M shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.

IRD Monitor News

No data

No data

IRD Earnings Analysis

No Data

No Data

People Also Watch